1437PPhase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC).
Saved in:
| Title: | 1437PPhase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC). |
|---|---|
| Authors: | Plummer, R1 (AUTHOR), Cook, N2 (AUTHOR), Arkenau, T3 (AUTHOR), Melear, J4 (AUTHOR), Redfern, C5 (AUTHOR), Spira, A I6 (AUTHOR), Chung, K7 (AUTHOR), Haddad, T8 (AUTHOR), Ramalingam, S S9 (AUTHOR), Wesolowski, R10 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 133285512 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1437PPhase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Plummer%2C+R%22">Plummer, R</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cook%2C+N%22">Cook, N</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arkenau%2C+T%22">Arkenau, T</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Melear%2C+J%22">Melear, J</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Redfern%2C+C%22">Redfern, C</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spira%2C+A+I%22">Spira, A I</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chung%2C+K%22">Chung, K</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Haddad%2C+T%22">Haddad, T</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ramalingam%2C+S+S%22">Ramalingam, S S</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wesolowski%2C+R%22">Wesolowski, R</searchLink><relatesTo>10</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133285512 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy292.059 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 1437PPhase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Plummer, R – PersonEntity: Name: NameFull: Cook, N – PersonEntity: Name: NameFull: Arkenau, T – PersonEntity: Name: NameFull: Melear, J – PersonEntity: Name: NameFull: Redfern, C – PersonEntity: Name: NameFull: Spira, A I – PersonEntity: Name: NameFull: Chung, K – PersonEntity: Name: NameFull: Haddad, T – PersonEntity: Name: NameFull: Ramalingam, S S – PersonEntity: Name: NameFull: Wesolowski, R IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 10 Text: 2018 Supplement Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 29 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
